Bafna Pharmaceuticals Ltd. | Small-cap | Healthcare
₹85.14
-0.06%
| Bafna Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.5B
Gross Profit 428.0M 29.34%
Operating Income 62.9M 4.31%
Net Income 41.5M 2.85%
EPS (Diluted) ₹1.76

Balance Sheet Metrics

Total Assets 1.5B
Total Liabilities 682.7M
Shareholders Equity 848.1M
Debt to Equity 0.81

Cash Flow Metrics

Operating Cash Flow 207.7M
Free Cash Flow 2.8M

Revenue & Profitability Trend

Bafna Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue1.5B1.5B1.2B851.4M712.2M
Cost of Goods Sold1.0B1.1B765.9M512.8M454.6M
Gross Profit428.0M455.6M387.6M338.6M257.6M
Operating Expenses105.9M142.1M66.3M70.6M26.4M
Operating Income62.9M74.0M120.7M66.1M61.4M
Pre-tax Income41.5M73.5M116.2M52.2M58.3M
Income Tax002.8M00
Net Income41.5M73.5M113.4M52.2M58.3M
EPS (Diluted)₹1.76₹3.11₹4.79₹2.21₹2.46

Income Statement Trend

Bafna Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets861.8M944.7M873.1M508.8M496.7M
Non-Current Assets669.0M532.1M422.7M392.6M368.0M
Total Assets1.5B1.5B1.3B901.4M864.7M
Liabilities
Current Liabilities518.5M540.8M464.8M220.1M243.1M
Non-Current Liabilities164.2M127.6M96.5M61.7M53.9M
Total Liabilities682.7M668.4M561.3M281.8M296.9M
Equity
Total Shareholders Equity848.1M808.4M734.5M619.6M567.7M

Balance Sheet Composition

Bafna Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income41.5M73.5M116.2M51.9M58.3M
Operating Cash Flow207.7M-32.7M-164.1M-93.7M-162.4M
Investing Activities
Capital Expenditures-218.0M-154.1M-65.2M-75.4M-60.9M
Investing Cash Flow-213.0M-149.1M-60.2M-65.6M-53.8M
Financing Activities
Dividends Paid-----
Financing Cash Flow----88.2M98.7M
Free Cash Flow2.8M-63.6M-32.7M21.9M-197.0M

Cash Flow Trend

Bafna Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 42.33
Price to Book 2.09
Price to Sales 1.21
PEG Ratio -0.98

Profitability Ratios

Profit Margin 2.85%
Operating Margin 7.42%
Return on Equity 5.02%
Return on Assets 2.61%

Financial Health

Current Ratio 1.66
Debt to Equity 33.25
Beta 0.12

Per Share Data

EPS (TTM) ₹1.76
Book Value per Share ₹35.58
Revenue per Share ₹61.81

Financial data is updated regularly. All figures are in the company's reporting currency.